henagliflozin/metformin (HR20033) / Jiangsu Hengrui Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
henagliflozin/metformin (HR20033) / Jiangsu Hengrui Pharma
NCT05120219: A Study to Assess the Effect of Food on HR20033 and Pharmacokinetic After Multiple Dose in Healthy Volunteers

Active, not recruiting
1
28
RoW
FDC tablet
Shandong Suncadia Medicine Co., Ltd.
Type II Diabetes
11/21
12/21

Download Options